100
Participants
Start Date
February 19, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Disclosure Toolkit
"Participants will receive a Disclosure Toolkit consisting of a family letter, gene information chatbot, and informational website to aid in communicating their genetic test results with at-risk relatives."
Abramson Cancer Center, Philadelphia
University of Pennsylvania
OTHER